{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:17:15Z","timestamp":1792513035718,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>An effective AIDS vaccine remains one of the highest priorities in HIV-research. Our recent study showed that vaccination of rhesus macaques with recombinant simian varicella virus (rSVV) vector \u2013 simian immunodeficiency virus (SIV) envelope and gag genes, induced neutralizing antibodies and cellular immune responses to SIV and also significantly reduced plasma viral loads following intravenous pathogenic challenge with SIV<jats:sub>MAC251<\/jats:sub>\/CX1.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Findings<\/jats:title>\n            <jats:p>The purpose of this study was to define cellular immunological correlates of protection in rSVV-SIV vaccinated and SIV challenged animals. Immunofluorescent staining and multifunctional assessment of SIV-specific T-cell responses were evaluated in both Experimental and Control vaccinated animal groups. Significant increases in the proliferating CD4+ T-cell population and polyfunctional T-cell responses were observed in all Experimental-vaccinated animals compared with the Control-vaccinated animals.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Increased CD4+ T-cell proliferation was significantly and inversely correlated with plasma viral load. Increased SIV-specific polyfunctional cytokine responses and increased proliferation of CD4+ T-cell may be crucial to control plasma viral loads in vaccinated and SIV<jats:sub>MAC251<\/jats:sub>\/CX1 challenged macaques.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1743-422x-9-160","type":"journal-article","created":{"date-parts":[[2012,8,13]],"date-time":"2012-08-13T22:13:50Z","timestamp":1344896030000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Increased cellular immune responses and CD4+ T-cell proliferation correlate with reduced plasma viral load in SIV challenged recombinant simian varicella virus - simian immunodeficiency virus (rSVV-SIV) vaccinated rhesus macaques"],"prefix":"10.1186","volume":"9","author":[{"given":"Bapi","family":"Pahar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne L","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Phelps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth S","family":"Didier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen","family":"deHaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preston A","family":"Marx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicki L","family":"Traina-Dorge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,8,13]]},"reference":[{"key":"1831_CR1","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.virol.2009.02.014","volume":"387","author":"B Pahar","year":"2009","unstructured":"Pahar B, Lackner AA, Piatak M Jr, Lifson JD, Wang X, Das A, Ling B, Montefiori DC, Veazey RS: Control of viremia and maintenance of intestinal CD4(+) memory T-cells in SHIV(162P3) infected macaques after pathogenic SIV(MAC251) challenge. Virology 2009, 387: 273-284.","journal-title":"Virology"},{"key":"1831_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/ni1296","volume":"7","author":"WC Koff","year":"2006","unstructured":"Koff WC, Johnson PR, Watkins DI, Burton DR, Lifson JD, Hasenkrug KJ, McDermott AB, Schultz A, Zamb TJ, Boyle R, Desrosiers RC: HIV vaccine design: insights from live attenuated SIV vaccines. Nat Immunol 2006, 7: 19-23.","journal-title":"Nat Immunol"},{"key":"1831_CR3","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1600-0684.1992.tb00574.x","volume":"21","author":"ML Marthas","year":"1992","unstructured":"Marthas ML, Miller CJ, Sutjipto S, Higgins J, Torten J, Lohman BL, Unger RE, Ramos RA, Kiyono H, McGhee JR, et al.: Efficacy of live-attenuated and whole-inactivated simian immunodeficiency virus vaccines against vaginal challenge with virulent SIV. J Med Primatol 1992, 21: 99-107.","journal-title":"J Med Primatol"},{"key":"1831_CR4","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","volume":"361","author":"S Rerks-Ngarm","year":"2009","unstructured":"Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, Premsri N, Namwat C, de Souza M, Adams E, et al.: Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 2009, 361: 2209-2220.","journal-title":"N Engl J Med"},{"key":"1831_CR5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nature10766","volume":"482","author":"DH Barouch","year":"2012","unstructured":"Barouch DH, Liu J, Li H, Maxfield LF, Abbink P, Lynch DM, Iampietro MJ, Sanmiguel A, Seaman MS, Ferrari G, et al.: Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys. Nature 2012, 482: 89-93.","journal-title":"Nature"},{"key":"1831_CR6","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nature10003","volume":"473","author":"SG Hansen","year":"2011","unstructured":"Hansen SG, Ford JC, Lewis MS, Ventura AB, Hughes CM, Coyne-Johnson L, Whizin N, Oswald K, Shoemaker R, Swanson T, et al.: Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine. Nature 2011, 473: 523-527.","journal-title":"Nature"},{"key":"1831_CR7","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1159\/000060324","volume":"3","author":"AM Arvin","year":"1999","unstructured":"Arvin AM, Mallory S, Moffat JF: Development of recombinant varicella-zoster virus vaccines. Contrib Microbiol 1999, 3: 193-200.","journal-title":"Contrib Microbiol"},{"key":"1831_CR8","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/rmv.437","volume":"14","author":"WL Gray","year":"2004","unstructured":"Gray WL: Simian varicella: a model for human varicella-zoster virus infections. Rev Med Virol 2004, 14: 363-381.","journal-title":"Rev Med Virol"},{"key":"1831_CR9","first-page":"22","volume":"58","author":"WL Gray","year":"2008","unstructured":"Gray WL: Simian varicella in old world monkeys. Comp Med 2008, 58: 22-30.","journal-title":"Comp Med"},{"key":"1831_CR10","doi-asserted-by":"publisher","first-page":"6483","DOI":"10.1016\/j.vaccine.2010.07.018","volume":"28","author":"V Traina-Dorge","year":"2010","unstructured":"Traina-Dorge V, Pahar B, Marx P, Kissinger P, Montefiori D, Ou Y, Gray WL: Recombinant varicella vaccines induce neutralizing antibodies and cellular immune responses to SIV and reduce viral loads in immunized rhesus macaques. Vaccine 2010, 28: 6483-6490.","journal-title":"Vaccine"},{"key":"1831_CR11","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.virol.2007.03.025","volume":"364","author":"Y Ou","year":"2007","unstructured":"Ou Y, Traina-Dorge V, Davis KA, Gray WL: Recombinant simian varicella viruses induce immune responses to simian immunodeficiency virus (SIV) antigens in immunized vervet monkeys. Virology 2007, 364: 291-300.","journal-title":"Virology"},{"key":"1831_CR12","doi-asserted-by":"publisher","first-page":"6839","DOI":"10.1016\/j.vaccine.2006.06.050","volume":"24","author":"B Pahar","year":"2006","unstructured":"Pahar B, Cantu MA, Zhao W, Kuroda MJ, Veazey RS, Montefiori DC, Clements JD, Aye PP, Lackner AA, Lovgren-Bengtsson K, Sestak K: Single epitope mucosal vaccine delivered via immuno-stimulating complexes induces low level of immunity against simian-HIV. Vaccine 2006, 24: 6839-6849.","journal-title":"Vaccine"},{"key":"1831_CR13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1182\/blood.V95.1.249","volume":"95","author":"MD Hazenberg","year":"2000","unstructured":"Hazenberg MD, Stuart JW, Otto SA, Borleffs JC, Boucher CA, de Boer RJ, Miedema F, Hamann D: T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART). Blood 2000, 95: 249-255.","journal-title":"Blood"},{"key":"1831_CR14","doi-asserted-by":"publisher","first-page":"8413","DOI":"10.1128\/JVI.74.18.8413-8424.2000","volume":"74","author":"A Kaur","year":"2000","unstructured":"Kaur A, Hale CL, Ramanujan S, Jain RK, Johnson RP: Differential dynamics of CD4(+) and CD8(+) T-lymphocyte proliferation and activation in acute simian immunodeficiency virus infection. J Virol 2000, 74: 8413-8424.","journal-title":"J Virol"},{"key":"1831_CR15","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1086\/314660","volume":"179","author":"JV Giorgi","year":"1999","unstructured":"Giorgi JV, Hultin LE, McKeating JA, Johnson TD, Owens B, Jacobson LP, Shih R, Lewis J, Wiley DJ, Phair JP, et al.: Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 1999, 179: 859-870.","journal-title":"J Infect Dis"},{"key":"1831_CR16","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.virol.2007.01.010","volume":"363","author":"B Pahar","year":"2007","unstructured":"Pahar B, Wang X, Dufour J, Lackner AA, Veazey RS: Virus-specific T-cell responses in macaques acutely infected with SHIV(sf162p3). Virology 2007, 363: 36-47.","journal-title":"Virology"},{"key":"1831_CR17","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1128\/JVI.02030-10","volume":"85","author":"MF Chevalier","year":"2011","unstructured":"Chevalier MF, Julg B, Pyo A, Flanders M, Ranasinghe S, Soghoian DZ, Kwon DS, Rychert J, Lian J, Muller MI, et al.: HIV-1-specific interleukin-21+ CD4+ T-cell responses contribute to durable viral control through the modulation of HIV-specific CD8+ T-cell function. J Virol 2011, 85: 733-741.","journal-title":"J Virol"},{"key":"1831_CR18","doi-asserted-by":"publisher","first-page":"8844","DOI":"10.1128\/JVI.78.16.8844-8851.2004","volume":"78","author":"PJ Norris","year":"2004","unstructured":"Norris PJ, Moffett HF, Yang OO, Kaufmann DE, Clark MJ, Addo MM, Rosenberg ES: Beyond help: direct effector functions of human immunodeficiency virus type 1-specific CD4(+) T-cells. J Virol 2004, 78: 8844-8851.","journal-title":"J Virol"},{"key":"1831_CR19","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1586\/erv.10.132","volume":"9","author":"DZ Soghoian","year":"2010","unstructured":"Soghoian DZ, Streeck H: Cytolytic CD4(+) T-cells in viral immunity. Expert Rev Vaccines 2010, 9: 1453-1463.","journal-title":"Expert Rev Vaccines"},{"key":"1831_CR20","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1182\/blood-2003-04-1203","volume":"103","author":"A Harari","year":"2004","unstructured":"Harari A, Petitpierre S, Vallelian F, Pantaleo G: Skewed representation of functionally distinct populations of virus-specific CD4 T-cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy. Blood 2004, 103: 966-972.","journal-title":"Blood"},{"key":"1831_CR21","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1126\/science.278.5342.1447","volume":"278","author":"ES Rosenberg","year":"1997","unstructured":"Rosenberg ES, Billingsley JM, Caliendo AM, Boswell SL, Sax PE, Kalams SA, Walker BD: Vigorous HIV-1-specific CD4+ T-cell responses associated with control of viremia. Science 1997, 278: 1447-1450.","journal-title":"Science"},{"key":"1831_CR22","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/417095a","volume":"417","author":"DC Douek","year":"2002","unstructured":"Douek DC, Brenchley JM, Betts MR, Ambrozak DR, Hill BJ, Okamoto Y, Casazza JP, Kuruppu J, Kunstman K, Wolinsky S, et al.: HIV preferentially infects HIV-specific CD4+ T-cells. Nature 2002, 417: 95-98.","journal-title":"Nature"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-9-160.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T20:04:48Z","timestamp":1630526688000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/1743-422X-9-160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,13]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1831"],"URL":"https:\/\/doi.org\/10.1186\/1743-422x-9-160","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,13]]},"assertion":[{"value":"14 February 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"160"}}